10X Genomics Inc (TXG) — Capital Reinvestment Ratio
10X Genomics Inc (TXG) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($43.21 Million) in capital expenditures ($687.00K). See net asset quality index of 10X Genomics Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
10X Genomics Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks 10X Genomics Inc's Capital Reinvestment Ratio across 2 annual periods. Check TXG capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for 10X Genomics Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for 10X Genomics Inc from 2019 to 2024. For live market cap and broader valuation context, see TXG market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.86x | $6.66 Million | $12.39 Million | ▲ +50.6% |
| 2019 | 1.24x | $34.63 Million | $42.77 Million | — |